Rolfe Lindsey

CIK 00016505043 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001650504

Recent Transactions

50 trades

Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2026-01-07+690,900→ 690,900 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-05-30+9,326→ 9,326 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-03-04+17,923→ 17,923 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-02-24+127,500→ 255,000 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-12-02+127,500→ 127,500 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-03-25+112,500→ 112,500 total
Award
Atreca, Inc.
Stock Option (right to buy)
2023-06-13+12,000→ 12,000 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-11-02$0.98/sh−2,353→ 113,691 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-11-02$0.98/sh−1,908→ 111,419 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-11-01−3,749→ 3,750 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-11-01+4,625→ 116,044 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-11-01−4,625→ 23,125 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-11-01+3,749→ 113,327 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-09-02$1.20/sh−2,545→ 109,578 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-09-01+5,063→ 50,625 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-09-01+5,063→ 112,123 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-08-02$1.46/sh−1,939→ 104,826 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-08-02$1.46/sh−2,391→ 107,060 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-08-01+4,625→ 109,451 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-08-01+3,749→ 106,765 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-08-01−4,625→ 27,750 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-08-01−3,749→ 7,499 total
Award
Atreca, Inc.
Stock Option (right to buy)
2022-06-08+12,000→ 12,000 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-06-02$0.64/sh−2,650→ 103,016 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-06-01+5,062→ 55,688 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-06-01+5,062→ 105,666 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-05-02$1.97/sh−2,348→ 100,604 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-05-02$1.97/sh−1,904→ 98,327 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-05-01−3,749→ 11,248 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-05-01−4,625→ 32,375 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-05-01+4,625→ 102,952 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-05-01+3,749→ 100,231 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-03-02$1.87/sh−10,585→ 96,482 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-03-02$1.87/sh−360→ 86,817 total
Award
Clovis Oncology, Inc.
Restricted Stock Units
2022-03-01+81,000→ 81,000 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-03-01+688→ 0 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-03-01+20,250→ 60,750 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-03-01+20,250→ 107,067 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-03-01+688→ 87,177 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-02-02$1.94/sh−2,021→ 84,357 total
Sale
Clovis Oncology, Inc.
Common Stock
2022-02-02$1.94/sh−2,493→ 86,489 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-02-01−3,750→ 14,997 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-02-01+3,750→ 86,378 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2022-02-01−4,625→ 37,000 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2022-02-01+4,625→ 88,982 total
Sale
Clovis Oncology, Inc.
Common Stock
2021-12-02$3.00/sh−346→ 82,628 total
Exercise/Conversion
Clovis Oncology, Inc.
Restricted Stock Units
2021-12-01−687→ 688 total
Exercise/Conversion
Clovis Oncology, Inc.
Common Stock
2021-12-01+687→ 82,974 total
Sale
Clovis Oncology, Inc.
Common Stock
2021-11-02$4.55/sh−1,884→ 79,987 total
Sale
Clovis Oncology, Inc.
Common Stock
2021-11-02$4.55/sh−2,325→ 82,287 total

Companies

Recent Filings

Address

CERO THERAPEUTICS HOLDINGS, INC. 201 HASKINS WAY, SUITE 230

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov